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Background: The risk of cardiovascular diseases (CVD) is increased tremendously among 
menopausal women, and there is an increasing demand for alternative therapies for managing 
factors like dyslipidemia that contribute to CVD development. Methods: In this study, 
Nigella sativa was evaluated for its hypolipidemic effects among menopausal women. In a 
randomised trial, hyperlipidemic menopausal women were assigned to treatment (n = 19) or 
placebo groups (n = 18), and given N. sativa or placebo for two months after their informed 
consents were sought. At baseline, blood samples were taken and at one month intervals 
thereafter until one month after the end of the study. Results: The results showed that N. 
sativa significantly improved lipid profiles of menopausal women (decreased total cholesterol, 
low density lipoprotein cholesterol and triglyceride, and increased high density lipoprotein 
cholesterol) more than the placebo treatment over 2 months of intervention. One month after 
cessation of treatment, the lipid profiles in the N. sativa-treated group tended to change 
towards the pretreatment levels. Conclusions: N. sativa is thought to have multiple 
mechanisms of action and is cost-effective. Therefore, it could be used by menopausal 
women to remedy hypercholesterolemia, with likely more benefits than with single 
pharmacological agents that may cause side effects. The use of N. sativa as an alternative 
therapy for hypercholesterolemia could have profound impact on the management of CVD 
among menopausal women especially in countries where it is readily available. 
  
Keyword: Clinical trial; Complementary medicine; Hyperlipidemia; Menopause; Nigella 
sativa; Plant bioresources 
 
